Global Medical REIT Inc (NYSE:GMRE) Receives Average Recommendation of “Buy” from Brokerages
Shares of Global Medical REIT Inc (NYSE:GMRE) have been assigned an average recommendation of “Buy” from the seven brokerages that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $13.63.
Several research analysts have recently weighed in on GMRE shares. B. Riley upped their price target on shares of Global Medical REIT from $13.00 to $15.00 and gave the company a “buy” rating in a report on Friday, December 20th. Zacks Investment Research lowered shares of Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Saturday, November 9th. Stifel Nicolaus boosted their price objective on shares of Global Medical REIT from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, December 17th. TheStreet raised shares of Global Medical REIT from a “c+” rating to a “b-” rating in a research report on Monday, October 14th. Finally, Janney Montgomery Scott raised shares of Global Medical REIT from a “neutral” rating to a “buy” rating and set a $14.50 price objective on the stock in a research report on Tuesday, January 7th.
Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. lifted its position in shares of Global Medical REIT by 68.8% in the second quarter. BlackRock Inc. now owns 2,225,649 shares of the company’s stock worth $23,368,000 after purchasing an additional 907,360 shares in the last quarter. Vanguard Group Inc. raised its position in Global Medical REIT by 22.7% during the second quarter. Vanguard Group Inc. now owns 1,974,041 shares of the company’s stock worth $20,727,000 after acquiring an additional 364,967 shares in the last quarter. State Street Corp raised its position in Global Medical REIT by 11.8% during the third quarter. State Street Corp now owns 714,435 shares of the company’s stock worth $8,284,000 after acquiring an additional 75,168 shares in the last quarter. Psagot Investment House Ltd. raised its position in Global Medical REIT by 14.2% during the third quarter. Psagot Investment House Ltd. now owns 639,021 shares of the company’s stock worth $7,285,000 after acquiring an additional 79,506 shares in the last quarter. Finally, Foundry Partners LLC bought a new stake in Global Medical REIT during the third quarter worth $5,186,000. 48.71% of the stock is currently owned by institutional investors and hedge funds.
Global Medical REIT (NYSE:GMRE) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.02 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by ($0.17). The company had revenue of $18.20 million during the quarter, compared to analyst estimates of $17.68 million. Global Medical REIT had a net margin of 23.42% and a return on equity of 5.49%. Equities analysts anticipate that Global Medical REIT will post 0.75 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 9th. Stockholders of record on Thursday, December 26th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 5.65%. The ex-dividend date was Tuesday, December 24th. Global Medical REIT’s dividend payout ratio is presently 102.56%.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Read More: Derivative
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.